A phase I trial of nab-paclitaxel/bevacizumab (AB160) nano-immunoconjugate therapy for metastatic gynecological malignancies: MC1371 (NCT02020707). This is an ASCO ...
This paper develops an algorithm to calculate the Brownian multivariate normal probability subject to any preset error tolerance criteria. The algorithm is founded ...
LONDON, Aug. 27, 2021 — Brytlyt announces they have been granted a patent by the United States Patent and Trademark Office for their ground-breaking algorithm that allows efficient and effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback